Hq5
Do Intervention and Evaluation Using Digital Health Services Prevent Sarcopenia in High‐Risk Non‐Older Adults? English Translation of the Japanese Guideline for Digital Health for the Prevention and Improvement of Sarcopenia and Frailty
Bibliographic Data
M.A. has disclosed financial relationships with Daiichi Sankyo Co. Ltd., MSD K.K. Toa Eiyo Co. Ltd., Towa Pharmaceutical Co. Ltd., Eisai Co. Ltd., Kracie Pharmaceutical Co. Ltd., Tsumura Pharmaceutical Co. Ltd., Tanabe Mitsubishi Pharma Corporation, Chugai Pharmaceutical Co. Ltd., Ono Pharmaceutical Co. Ltd., Takeda Pharmaceutical Co. Ltd., Astellas Pharma Inc., Bayer Yakuhin Ltd.
Digital health · Disease prevention · Guideline · Health care · MEDLINE · Psychological intervention · Sarcopenia · Telemedicine · Frailty in Older Adults · Nutrition and Health in Aging · Physical Activity and Health
| Citation velocity | historical |
|---|---|
| Highly cited | No |